News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
172,490 Results
Type
Article (9903)
Company Profile (38)
Press Release (162549)
Section
Business (46849)
Career Advice (302)
Deals (7666)
Drug Delivery (14)
Drug Development (22887)
Employer Resources (42)
FDA (4679)
Job Trends (3759)
News (81363)
Policy (6451)
Tag
Academia (844)
Alliances (15396)
Alzheimer's disease (394)
Approvals (4689)
Artificial intelligence (58)
Bankruptcy (42)
Best Places to Work (3334)
Breast cancer (37)
Cancer (437)
Cardiovascular disease (30)
Career advice (252)
Cell therapy (83)
Clinical research (17680)
Collaboration (179)
COVID-19 (1084)
C-suite (28)
Cystic fibrosis (29)
Data (505)
Diabetes (47)
Diagnostics (2607)
Earnings (14905)
Employer resources (36)
Events (21762)
Executive appointments (104)
FDA (4904)
Funding (142)
Gene therapy (46)
GLP-1 (155)
Government (1074)
Healthcare (4558)
Infectious disease (1123)
Inflammatory bowel disease (41)
Interviews (32)
IPO (3213)
Job creations (537)
Job search strategy (228)
Layoffs (55)
Legal (704)
Lung cancer (52)
Manufacturing (65)
Medical device (3618)
Medtech (3619)
Mergers & acquisitions (4513)
Metabolic disorders (126)
Neuroscience (468)
NextGen Class of 2024 (1545)
Non-profit (854)
Northern California (487)
Obesity (77)
Opinion (41)
Patents (30)
People (13200)
Phase I (6344)
Phase II (7939)
Phase III (5473)
Pipeline (189)
Postmarket research (426)
Preclinical (2800)
Press Release (31)
Radiopharmaceuticals (62)
Rare diseases (78)
Real estate (1492)
Regulatory (5085)
Research institute (834)
Resumes & cover letters (46)
Southern California (380)
Startups (1077)
United States (3992)
Vaccines (161)
Weight loss (39)
Date
Today (30)
Last 7 days (164)
Last 30 days (647)
Last 365 days (9824)
2024 (9780)
2023 (11482)
2022 (17549)
2021 (18454)
2020 (17470)
2019 (11981)
2018 (9087)
2017 (8676)
2016 (8115)
2015 (9318)
2014 (6475)
2013 (5153)
2012 (5593)
2011 (5999)
2010 (5028)
Location
Africa (171)
Arizona (32)
Asia (10224)
Australia (1824)
California (1039)
Canada (389)
China (87)
Colorado (50)
Connecticut (57)
Europe (24479)
Florida (166)
Georgia (41)
Illinois (71)
Indiana (38)
Japan (28)
Kansas (36)
Maryland (162)
Massachusetts (855)
Michigan (57)
Minnesota (34)
New Jersey (280)
New York (288)
North Carolina (217)
Northern California (487)
Ohio (32)
Pennsylvania (192)
South America (207)
Southern California (380)
Texas (145)
Washington State (113)
172,490 Results for "rapid micro biosystems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference
November 8, 2024
·
1 min read
Press Releases
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results
November 4, 2024
·
9 min read
Business
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2024.
May 3, 2024
·
9 min read
Business
Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024
October 23, 2024
·
1 min read
Genetown
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”) today announced that the Company will participate in the virtual KeyBanc Life Sciences & MedTech Investor Forum on March 19, 2024.
March 12, 2024
·
1 min read
Genetown
Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024
Rapid Micro Biosystems, Inc. announced that it will exhibit at the 2024 Parenteral Drug Association Annual Meeting from March 25 – 27, 2024 in Long Beach, CA.
March 19, 2024
·
4 min read
Business
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2024 financial results prior to the market open on Friday, May 3, 2024.
April 18, 2024
·
1 min read
Genetown
Rapid Micro Biosystems to Participate in Upcoming March 2024 Investor Conferences
Rapid Micro Biosystems, Inc., an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, announced that the Company will participate in the following investor conferences.
February 27, 2024
·
1 min read
Genetown
Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System
Rapid Micro Biosystems, Inc. today announced that it expects the commercial launch of the Growth Direct Rapid Sterility application by mid-year 2024.
January 10, 2024
·
7 min read
Business
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”) today announced its financial results for the fourth quarter and full year ended December 31, 2023.
March 1, 2024
·
10 min read
1 of 17,249
Next
